Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 29 results.
User Information
Export Records
  1. 1.   Evaluation of the AV7909 Anthrax Vaccine Toxicity in Sprague Dawley Rats Following Three Intramuscular Administrations
  2. Rao, Veena V; Godin, C Steven; Lacy, Michael J; Inglefield,Jon; Park, Sukjoon; Blauth, Bruna; Reece, Joshua J; Ionin, Boris; Savransky, Vladimir
  3. International journal of toxicology. 2021, Jul 19; 10915818211031239.
  1. 2.   Seneca Valley Virus Exploits TEM8, a Collagen Receptor Implicated in Tumor Growth
  2. Evans, David J.; Wasinger, Alexa M.; Brey, Robert N.; Dunleavey, James; St Croix, Brad; Bann, James G.
  3. Frontiers in oncology. 2018, Nov 6; 8
  1. 3.   TEM8/ANTXR1 Blockade Inhibits Pathological Angiogenesis and Potentiates Tumoricidal Responses against Multiple Cancer Types
  2. Chaudhary, A.; Hilton, M. B.; Seaman, S.; Haines, D. C.; Stevenson, S.; Lemotte, P. K.; Tschantz, W. R.; Zhang, X. Y. M.; Saha, S.; Fleming, T.; St Croix, B.
  3. Cancer Cell. 2012, Feb; 21(2): 212-226.
  1. 4.   The cell surface structure of tumor endothelial marker 8 (TEM8) is regulated by the actin cytoskeleton
  2. Yang, M. Y.; Chaudhary, A.; Seaman, S.; Dunty, J.; Stevens, J.; Elzarrad, M. K.; Frankel, A. E.; Croix, B. S.
  3. Biochimica Et Biophysica Acta-Molecular Cell Research. 2011, Jan; 1813(1): 39-49.
  1. 5.   Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvants
  2. Klinman, D. M.; Klaschik, S.; Tomaru, K.; Shirota, H.; Tross, D.; Ikeuchi, H.
  3. Vaccine. 2010, Feb; 28(8): 1919-1923.
  1. 6.   Anthrax prevention and treatment: utility of therapy combining antibiotic plus vaccine
  2. Klinman, D. M.; Yamamoto, M.; Tross, D.; Tomaru, K.
  3. Expert Opinion on Biological Therapy. 2009, Dec; 9(12): 1477-86.
  1. 7.   Host-Derived Tumor Endothelial Marker 8 Promotes the Growth of Melanoma
  2. Cullen, M.; Seaman, S.; Chaudhary, A.; Yang, M. Y.; Hilton, M. B.; Logsdon, D.; Haines, D. C.; Tessarollo, L.; St Croix, B.
  3. Cancer Research. 2009 69(15): 6021-6026.
  1. 8.   Effect of CpG oligonucleotides on vaccine-induced B cell memory
  2. Tross, D.; Klinman, D. M.
  3. Journal of Immunology. 2008 181(8): 5785-5790.
  1. 9.   Low doses of antigen coupled to anti-CR2 mAbs induce rapid and enduring IgG immune responses in mice and in cynomolgus monkeys
  2. Whipple, E. C.; Ditto, A. H.; Shanahan, R. S.; Gatesman, J. J.; Little, S. F.; Taylor, R. P.; Lindorfer, M. A.
  3. Molecular Immunology. 2007, Jan; 44(4): 377-388.
  1. 10.   Defensin participation in innate and adaptive immunity
  2. Yang, D.; Liu, Z. H.; Tewary, P.; Chen, Q.; De la Rosa, G.; Oppenheim, J. J.
  3. Current Pharmaceutical Design. 2007 13(30): 3131-3139.
  1. 11.   Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine
  2. Mikszta, J. A.; Dekker, J. P.; Harvey, N. G.; Dean, C. H.; Brittingham, J. M.; Huang, J.; Sullivan, V. J.; Dyas, B.; Roy, C. J.; Ulrich, R. G.
  3. Infection and Immunity. 2006, Dec; 74(12): 6806-6810.
  1. 12.   Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice
  2. Lee, J. S.; Groebner, J. L.; Hadjipanayis, A. G.; Negley, D. L.; Schmaljohn, A. L.; Welkos, S. L.; Smith, L. A.; Smith, J. F.
  3. Vaccine. 2006, Nov; 24(47-48): 6886-6892.
  1. 13.   The NCI60 human tumour cell line anticancer drug screen
  2. Shoemaker, R. H.
  3. Nature Reviews Cancer. 2006, Oct; 6(10): 813-823.
  1. 14.   Anthrax vaccines: Pasteur to the present
  2. Scorpio, A.; Blank, T. E.; Day, W. A.; Chabot, D. J.
  3. Cellular and Molecular Life Sciences. 2006, Oct; 63(19-20): 2237-2248.
  1. 15.   Enhancing molecular flux through nanopores by means of attractive interactions
  2. Kasianowicz, J. J.; Nguyen, T. L.; Stanford, V. M.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, Aug; 103(31): 11431-11432.
  1. 16.   Anthrax biosensor, protective antigen ion channel asymmetric blockade
  2. Halverson, K. M.; Panchal, R. G.; Nguyen, T. L.; Gussio, R.; Little, S. F.; Misakian, M.; Bavari, S.; Kasianowicz, J. J.
  3. Journal of Biological Chemistry. 2005, OCT 7; 280(40): 34056-34062.
  1. 17.   Dendritic cells endocytose Bacillus anthracis spores: Implications for anthrax pathogenesis
  2. Brittingham, K. C.; Ruthel, G.; Panchal, R. G.; Fuller, C. L.; Ribot, W. J.; Hoover, T. A.; Young, H. A.; Anderson, A. O.; Bavari, S.
  3. Journal of Immunology. 2005, MAY 1; 174(9): 5545-5552.
  1. 18.   Purified Bacillus anthracis lethal toxin complex formed in Vitro and during infection exhibits functional and biological activity
  2. Panchal, R. G.; Halverson, K. M.; Ribot, W.; Lane, D.; Kenny, T.; Abshire, T. G.; Ezzell, J. W.; Hoover, T. A.; Powell, B.; Little, S.; Kasianowicz, J. J.; Bavari, S.
  3. Journal of Biological Chemistry. 2005, MAR 18; 280(11): 10834-10839.
  1. 19.   Electrophysiological analysis of anthrax toxin interactions
  2. Halverson, K. M.; Panchal, R. G.; Nguyen, T. L.; Gussio, R.; Little, S. F.; Misakian, M.; Bavari, S.; Kasianowicz, J. J.
  3. Biophysical Journal. 2005, JAN; 88(1, Part 2, Suppl. S): 476A-477A.
  1. 20.   The evolving field of biodefence: Therapeutic developments and diagnostics
  2. Burnett, J. C.; Henchal, E. A.; Schmaljohn, A. L.; Bavari, S.
  3. Nature Reviews Drug Discovery. 2005 4(4): 281-297.
  1. 21.   Construction of a rhamnose mutation in Bacillus anthracis affects adherence to macrophages but not virulence in guinea pigs
  2. Bozue, J. A.; Parthasarathy, N.; Phillips, L. R.; Cote, C. K.; Fellows, P. F.; Mendelson, I.; Shafferman, A.; Friedl, er
  3. Microbial Pathogenesis. 2005, JAN; 38(1): 1-12.
  1. 22.   Involvement of domain II in toxicity of anthrax lethal factor
  2. Liang, X. D.; Young, J. J.; Boone, S. A.; Waugh, D. S.; Duesbery, N. S.
  3. Journal of Biological Chemistry. 2004, DEC 10; 279(50): 52473-52478.
  1. 23.   Three-dimensional model of the pore form of anthrax protective antigen. Structure and biological implications
  2. Nguyen, T. L.
  3. Journal of Biomolecular Structure & Dynamics. 2004, DEC; 22(3): 253-265.
  1. 24.   Tumor endothelial markers: new targets for cancer therapy
  2. Nanda, A.; St Croix, B.
  3. Current Opinion in Oncology. 2004, JAN; 16(1): 44-49.
  1. 25.   TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI)
  2. Nanda, A.; Carson-Walter, E. B.; Seaman, S.; Barber, T. D.; Stampfl, J.; Singh, S.; Vogelstein, B.; Kinzler, K. W.; St Croix, B.
  3. Cancer Research. 2004 64(3): 817-820.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel